SavedAdd your journal

Journals / Ankara Medical Journal / 2020 / Cilt: 20 - Sayı: 1

ENDOVASCULAR TREATMENT OPTIONS IN CENTRAL VENOUS STENOSIS AND OCCLUSION: ANGIOPLASTY OR STENT?

SANTRAL VENÖZ STENOZ VE OKLÜZYONLARDA ENDOVASKÜLER TEDAVİ SEÇENEKLERİ; ANJİOPLASTİ Mİ, STENT Mİ?

Ali FIRAT
Behlül İGÜS
Hüseyin Yüce BİRCAN
Pages
242–250
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore, PTS should only be preferred for PTA-resistantlesions or concurrent lesions.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The purpose of this study was to compare the patency rate outcomes and efficacy of percutaneoustransluminal angioplasty (PTA) versus percutaneous transluminal stenting (PTS) for the treatment of centralvein stenosis and occlusion in hemodialysis patients.Materials and Methods: A total of 71 chronic hemodialysis patients (36 males, 35 females) with 142 eventsof central venous stenosis or occlusion underwent 109 endovascular interventions between March 2013 andJune 2018.
📊
Key Findings & Data:The clinical follow-up of the patients was performed with control venography at 1, 3, and 6 months,and then at 6-month intervals for asymptomatic patients.Results: PTA was applied to 45 patients and PTS to 26 patients during the study period.
💡
Conclusion & Impact:Therefore, PTS should only be preferred for PTA-resistantlesions or concurrent lesions.
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: The purpose of this study was to compare the patency rate outcomes and efficacy of percutaneoustransluminal angioplasty (PTA) versus percutaneous transluminal stenting (PTS) for the treatment of centralvein stenosis and occlusion in hemodialysis patients.Materials and Methods: A total of 71 chronic hemodialysis patients (36 males, 35 females) with 142 eventsof central venous stenosis or occlusion underwent 109 endovascular interventions between March 2013 andJune 2018. The clinical follow-up of the patients was performed with control venography at 1, 3, and 6 months,and then at 6-month intervals for asymptomatic patients.Results: PTA was applied to 45 patients and PTS to 26 patients during the study period. At 3, 6,12 and 24months, primary patency rates were 97.74%, 88.23%, 73.76% and 50.76% respectively in the PTA group and96.23%, 92.34%, 65.96% and 47% in the PTS group. Assisted primary patency at 3, 6, and 12 months was97.73%, 90.76%, and 75.92% respectively in the PTA group and 96.25%, 84.38%, and 79.87% in the PTS group.No statistically significant difference was determined between the groups in respect of primary and assistedpatency rates (p=0.216, p=0.121). The average number of interventions in the PTS group (2.62± 1.23) wassignificantly higher than that in the PTA group (1.43±0.62).Conclusion: Endovascular treatment is a safe and effective method in the management of central veinocclusion. PTS does not result in longer patency in the treatment, but conversely incurs greater costs andnecessitates more interventions to provide patency. Therefore, PTS should only be preferred for PTA-resistantlesions or concurrent lesions.

Özet

Amaç: Bu çalışmada santral ven darlığı veya tıkanıklığı olan hemodiyaliz hastalarının perkütan transluminal anjiyoplasti (PTA) ve perkütan transluminal stentleme (PTS) ile tedavinin etkinliğini ve patensi oranlarının sonuçları karşılaştırılması amaçlanmıştır. Materyal ve Metot: Yüz kırk iki santral venöz darlığı veya tıkanması olan 71 kronik hemodiyaliz hasta grubunda (36 erkek, 35 kadın) Mart 2013 ile Haziran 2018 arasında 109 endovasküler girişim uygulandı. Hastaların klinik takibi kontrol venografi ile 1, 3 ve 6. aylarda yapıldı ve asemptomatik hastalarda 6 ay intervallerle kontrollere devam edildi. Bulgular: Tedavi süresince 45 hastada PTA, 26 hastada PTS işlemi yapıldı. Primer açıklık oranları sırasıyla 3., 6., 12. ve 24. aylarda PTA grubunda; % 97,74, %88,23, % 73,76, % 50,76 ve PTS grubunda; % 96,23, %92,34, %65,96, %47 olarak saptandı. Yardımcı primer açıklık oranları sırasıyla 3., 6. ve12. aylarda PTA grubunda; % 97,73, %90,76, %75,92 ve PTS grubunda; %96,25 %84,38, %79,87 olarak saptandı. Primer ve yardımcı açıklık oranları açısından gruplar arasında istatistiksel olarak anlamlı bir fark bulunmadı (p=0,216, p=0,121). PTS grubundaki ortalama müdahale sayısı (2,62 ± 1,23), PTA grubundan (1,43 ± 0,62) anlamlı derecede yüksekti. Sonuç: Endovasküler tedavi, santral ven tıkanıklığı tedavisinde güvenli ve etkili bir yöntemdir. PTS, tedavide daha uzun açıklık sağlamamakla birlikte aksine tedaviye daha yüksek ek maliyetler ve damar açıklığını sağlamak için daha fazla girişimler getirmektedir. PTS, anjioplasti dirençli veya sık tekrarlayan lezyonlarda tercih edilmelidir.

🔖

Cite This Article

FIRAT, A., İGÜS, B., BİRCAN, H. Y. (2022). ENDOVASCULAR TREATMENT OPTIONS IN CENTRAL VENOUS STENOSIS AND OCCLUSION: ANGIOPLASTY OR STENT?. Ankara Medical Journal, Cilt: 20 - Sayı: 1, 242–250. https://ajindex.com/articles/441833

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Agarwal AK. Central vein stenosis. Am J Kidney Dis. 2013;61(6):1001-15
  2. Osman OO, El-Magzoub A, Elamin S. Prevalence and risk factors of central venous stenosis among prevalent hemodialysispatients, a single center experience. Arab J Nephrol Transpl.2014;7(1):45-47
  3. Surratt RS, Picus D, Hicks ME, Darcy MD,Kleinhoffer M,Jendrisak M. The importance of preoperative evaluation of the subclavian vein in dialysis access planning. AJR Am J Roentgenol 1991;156(3):623-5
  4. Criado E, Marston WA, Jaques PF, Mauro MA, Keagy BA. Proximal venous out flow obstruction in patients with upper extremity arteriovenous dialysis access. Ann Vasc Surg 1994;8:530–5
  5. Maskova J, Komarkova J, Kivanek J, Danes J, Slavíková M. Endovascular treatment of central vein stenoses and/or occlusions in hemodialysispatients. Cardiovasc Intervent Radiol. 2003;26(1):27-30
  6. Oderich GS, Treiman GS, Schneider P, Bhirangi K. Stent placement for treatment of central and peripheral venous obstruction: A long-term multi-institutional experience. J Vasc Surg. 2000;32(4):760-9
  7. Schwab SJ, Quarles LD, Middleton JP, Cohan RH, Saeed M, Dennis VW. Hemodialysis-associated subclavian vein stenosis. Kidney Int 1988;33:1156-9
  8. Vanholder R, Lameire N, Verbanck J, van Rattinghe R, Kunnen M,Ringoir S. Complications of subclavian catheter hemodialysis: a 5 year prospective study in 257 consecutive patients. Int J Artif Organs 1982;5:297-303
  9. Bambauer R, Inniger R, Pirrung KJ, Schiel R, Dahlem R. Complications and side effects associated with large-bore catheters in the subclavian and internal jugular veins. Artif Organs 1994;18:318-21
  10. Dethlefsen SM, Shepro D, D’Amore PA. Comparison of the effects of mechanical stimulation on venous and arterial smooth muscle cells invitro. J Vasc Res 1996;33:405-13
  11. Wisselink W, Money SR, Becker MO, Rice KLi. et al. Comparison of operative reconstruction and percutaneous balloon dilatation for central venous obstruction. Am J Surg 1993;166:200-4
  12. Money S, Bhatia D, Daharamsy S, Mulingtapang R, Shaw D, Ramee S. Comparison of surgical bypass, percutaneous balloon dilatation (PTA),and PTA with stent placement in the treatment of central venous occlusion in the dialysis patient: one year follow-up. Int Angiol 1995;14:176
  13. Glanz S, Gordon D, Butt KM, Hong J, Adamson R, Sclafani SJ. Dialysis access fistulas: treatment of stenoses by transluminal angioplasty. Radiology. 1984;152(3):637-42
  14. Nael K, Kee ST, Solomon H, Katz SG. Endovascular manage